Skip to main content

CADANCE - A Phase 2 Study of Sotatercept for Cpc-PH Treatment

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Acceleron Pharma

Start Date

March 5, 2024

End Date

May 15, 2028
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Acceleron Pharma

Start Date

March 5, 2024

End Date

May 15, 2028